4.5 Article

Cholesterolomics: An update

期刊

ANALYTICAL BIOCHEMISTRY
卷 524, 期 -, 页码 56-67

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ab.2017.01.009

关键词

Cholesterol; Oxysterols; Cholestenoic acids; Derivatisation; Mass spectrometry

资金

  1. UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I001735/1, BB/N015932/1, BB/L001942/1]
  2. Welsh Government (Life Sciences Research Network Wales award)
  3. European Regional Development Fund/Welsh Government
  4. Imperial College Healthcare Charities
  5. Biotechnology and Biological Sciences Research Council [BB/L001942/1, BB/N015932/1, BB/I001735/1] Funding Source: researchfish
  6. BBSRC [BB/L001942/1, BB/I001735/1, BB/N015932/1] Funding Source: UKRI

向作者/读者索取更多资源

Cholesterolomics can be regarded as the identification and quantification of cholesterol, its precursors post squalene, and metabolites of cholesterol and of its precursors, in a biological sample. These molecules include 1,25-dihydroxyvitamin D-3, steroid hormones and bile acids and intermediates in their respective biosynthetic pathways. In this short article we will concentrate our attention on intermediates in bile acid biosynthesis pathways, in particular oxysterols and cholestenoic acids. These molecular classes are implicated in the aetiology of a diverse array of diseases including autoimmune disease, Parkinson's disease, motor neuron disease, breast cancer, the lysosomal storage disease Niemann-Pick type C and the autosomal recessive disorder Smith-Lemli-Opitz syndrome. Mass spectrometry (MS) is the dominant technology for sterol analysis including both gas-chromatography (GC)-MS and liquid chromatography (LC)-MS and more recently matrix-assisted laser desorption/ionisation (MALDI)-MS for tissue imaging studies. Here we will discuss exciting biological findings and recent analytical improvements. (C) 2017 The Authors. Published by Elsevier Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据